Advertisement

Activation of Proto-Oncogenes in Human Brain Tumors

  • Masabumi Shibuya
  • Hitoshi Yamazaki
  • Yoshito Ohba
  • Yasuhisa Fukui
  • Yoshito Ueyama
  • Norikazu Tamaoki

Abstract

Recent studies on carcinogenesis have revealed that genetic alteration, including both activation of proto-oncogenes and inactivation of anti-oncogenes, are crucial for initiation and progression of human malignant lesions. Glioblastoma multiforme (astrocytoma grades III and IV) is recognized as the major malignant type of tumor of the human brain. Several proto-oncogenes were found to be activated in glioblastoma. The epidermal growth factor (EGF) receptor gene (c-erbB gene) was amplified in about one-third of these tumors [1,2]. Other oncogenes or possible oncogenes, c-myc [3], N-myc [4], gli [5] and ros-1 [6] genes were also observed to be amplified or rearranged. However, the presence of activation of the latter four genes in glioblastoma is thought to be rare. Thus, the activation of proto-oncogenes in the DNA level, in about one-half of the glioblastoma multiforme in humans is still unclear. Furthermore, although the EGF receptor gene was found to be frequently amplified in these tumors, it has not been fully determined whether or not these amplified genes are changed structurally and functionally.

Keywords

Epidermal Growth Factor Receptor Human Epidermal Growth Factor Receptor Glioblastoma Multiforme Mutate Epidermal Growth Factor Receptor Epidermal Growth Factor Receptor Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Libermann TA, Nusbaum HR, Razon N, Kris R, Lax I, Soreq H, Whittle N, Waterfield MD, Ullrich A, Schiessinger J (1985) Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature 313: 144–147PubMedCrossRefGoogle Scholar
  2. 2.
    Wong AJ, Bigner SH, Bigner DD, Kinzler KW, Hamilton SR, Vogelstein B (1987) Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sei USA 84: 6899–6903CrossRefGoogle Scholar
  3. 3.
    Trent J, Meitzer P, Rosenblum M, Harsh G, Kinzler K, Mashal R, Fleiberg A, Vogelstein B (1986) Evidence for rearrangement, amplification, and expression of c-myc in a human glioblastoma. Proc Natl Acad Sei USA 83: 470–473CrossRefGoogle Scholar
  4. 4.
    Garson JA, Mcintyre PG, Kemshead JT (1985) N-myc amplification in malignant astrocytoma. Lancet 28: 718–719CrossRefGoogle Scholar
  5. 5.
    Kinzler KW, Bigner SH, Bigner DD, Trent JM, Law ML, O’Brien SJ, Wong AJ, Vogelstein B (1987) Identification of an amplified, highly expressed gene in a human glioma. Science 236: 70–73PubMedCrossRefGoogle Scholar
  6. 6.
    Birchmeier C, Sharma S, Wigler M (1987) Expression and rearrangement of the ROS1 gene in human glioblastoma cells. Proc Natl Acad Sei USA, 84: 9270–9274CrossRefGoogle Scholar
  7. 7.
    Yamazaki H, Fukui Y, Ueyama Y, Tamaoki N, Kawamoto T, Taniguchi S, Shibuya M (1988) Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors. Mol Cell Biol 8: 1816–1820PubMedGoogle Scholar
  8. 8.
    Yamazaki H, Ohba Y, Tamaoki N, Shibuya M (1990) A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumors. Jpn J Cancer Res 81: 773–779PubMedCrossRefGoogle Scholar
  9. 9.
    Humphrey PA, Wong AJ, Vogelstein B, Friedman HS, Werner MH, Bigner DD, Bigner SH (1988) Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts. Cancer Res 48: 2231–2238PubMedGoogle Scholar
  10. 10.
    Humphrey PA, Wong AJ, Vogelstein B, Zalutsky MR, Fuller GN, Archer GE, Friedman HS, Kwatra MM, Bigner SH, Bigner DD (1990) Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma. Proc Natl Acad Sei USA 87: 4207–4211CrossRefGoogle Scholar
  11. 11.
    Kawai S, Nishizawa M (1984) New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol 4: 1172–1174PubMedGoogle Scholar
  12. 12.
    Ullrich A, Coussens L, Hayflick JS, Dull TJ, Gray A, Tam AW, Lee J, Yarden Y, Libermann TA, Schlessinger J, Downward J, Mayes ELV, Whittle N, Waterfild MD, seeburg PH (1984) Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 309: 418–425PubMedCrossRefGoogle Scholar
  13. 13.
    Ishii S, Xu Y-H, Stratton RH, Roe BA, Merlino, GT, Pastan I (1985) Characterization and sequence of the promotor region of the human epidermal growth factor receptor gene. Proc Natl Acad Sei USA 82: 4920 - 4924CrossRefGoogle Scholar
  14. 14.
    Haley J, Whittle N, Bennett P, Kinchington D, Ullrich A, Waterfield M (1984) The human EGF receptor gene: Structure of the llOkb locus and identification of sequences regulating its transcription. Oncogene Res 1: 375–396Google Scholar
  15. 15.
    Nilsen TW, Maroney PA, Goodwin RG, Rottman F, Crittenden LB, Raines MA, Kung, H-J (1985) c-erbB activation in ALV-induced erythroblastosis: Novel RNA processing and promoter insertion result in expression of an amino-truncated EGF receptor. Cell 41: 719–726Google Scholar
  16. 16.
    Bigner SH, Mark J, Burger MP, Mahaley MS Jr, Bullard DE, Muhlbaier LH, Bigner DD (1988) Specific chromosomal abnormalities in malignant human giomas. Cancer Res 88: 405–411Google Scholar

Copyright information

© Springer-Verlag Tokyo 1991

Authors and Affiliations

  • Masabumi Shibuya
    • 1
  • Hitoshi Yamazaki
    • 1
    • 2
  • Yoshito Ohba
    • 1
    • 3
  • Yasuhisa Fukui
    • 1
  • Yoshito Ueyama
    • 2
  • Norikazu Tamaoki
    • 2
  1. 1.Institute of Medical ScienceUniversity of TokyoMinato-ku, Tokyo, 108Japan
  2. 2.Department of PathologyTokai UniversityIsehara, KanagawaJapan
  3. 3.Institute of Clinical EndocrinologyTokyo Women’s Medical CollegeShinjuku-ku, Tokyo, 162Japan

Personalised recommendations